Uroxatral is a brand-name medication that contains alfuzosin as its active ingredient. It belongs to the men’s health therapeutic class and is supplied as a 10 mg pill. In Hong Kong, Uroxatral is a prescription-only product regulated by the Department of Health’s Pharmacy and Poisons Branch. The medication is primarily used to relieve urinary symptoms associated with an enlarged prostate, a condition medically known as benign prostatic hyperplasia (BPH).
Alfuzosin is an α₁-adrenergic receptor antagonist. These receptors are found in the smooth muscle of the prostate, bladder neck, and urethra. By selectively blocking the α₁-receptors, alfuzosin causes the smooth muscle to relax. This relaxation widens the urinary passage, making it easier to start and maintain a urine flow.
Key pharmacologic points:
Uroxatral is approved in Hong Kong for the relief of urinary obstruction associated with benign prostatic hyperplasia. The medication helps reduce symptoms such as:
It is intended for adult men with BPH and is not indicated for prostate cancer, urinary tract infections, or other non-BPH urinary problems.
Note: Specific interaction data for Uroxatral is limited; patients should inform their healthcare provider about all medicines, supplements, and herbal products they are taking.
Special dosing considerations: No routine dose adjustments are required for most patients, but clinicians may modify the regimen for severe liver disease or when strong CYP3A4 inhibitors are co-prescribed.
This article provides educational information about Uroxatral and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Uroxatral (alfuzosin) and tamsulosin both belong to the α₁-blocker class, but they differ in receptor selectivity and dosing schedules. Alfuzosin is taken once daily after a meal, whereas tamsulosin is often taken on an empty stomach. Their side-effect profiles are similar, though individual tolerability can vary.
Yes, many men with hypertension also use alfuzosin. However, because alfuzosin can lower blood pressure, clinicians may monitor blood pressure more closely and adjust antihypertensive medications if needed.
There is no direct pharmacologic interaction, but both drugs can cause blood-pressure changes. Patients should discuss timing and dosing with their doctor to avoid additive hypotensive effects.
Alfuzosin is not a controlled substance and does not appear on standard drug-screening panels used for employment or athletic testing.
Alfuzosin tablets are formulated to resist moderate humidity, but prolonged exposure to moisture can degrade potency. Store the medication in a dry place, and discard any tablets that appear discolored or crumbled.
Uroxatral is a prescription medication; you should carry a copy of the prescription or a doctor's note when traveling. Some countries may require additional documentation, so checking local regulations before departure is advisable.
Sit or lie down immediately to prevent falls, and avoid standing up quickly. If dizziness persists or is accompanied by fainting, seek medical attention promptly.
Alfuzosin’s absorption is not severely affected by food, but taking the pill after a meal helps minimize postural hypotension. Grapefruit juice, however, can inhibit CYP3A4 and potentially raise drug levels, so it should be avoided.
Brand-name Uroxatral is typically priced higher than generic alfuzosin tablets. Patients may discuss generic alternatives with their pharmacist or physician to reduce out-of-pocket expenses.
Many users notice improvement in urinary flow within a few days, while full symptom relief often occurs after 2 to 4 weeks of consistent daily dosing.
